← back to search

Alexander Karpov

Novartis (Switzerland) · CH
Area of research
Immunology · Dermatology
Research interest
Research interests include Secukinumab, Medicine, Psoriasis, Psoriasis Area and Severity Index, Etanercept, and Itching.
h-index
—
citations
1,997
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials
International Journal of Dermatology 2016cited by 45position: middledoi
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
New England Journal of Medicine 2014cited by 1,952position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Boni E. Elewski · University of Alabama at Birmingham2 papers (2014–2016)— · 2 papers (2014–2016)Mark Lebwohl · Mount Sinai Hospital2 papers (2014–2016)C. Papavassilis · Novartis (Switzerland)2 papers (2014–2016)Silvia Helou · Novartis (Switzerland)1 papers (2014–2014)Stephen K. Tyring · The University of Texas at Austin1 papers (2014–2014)Kristian Reich · Universität Hamburg1 papers (2014–2014)Kim Papp · Goethe University Frankfurt1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2016–2016)Rodney Sinclair · Melbourne Health1 papers (2016–2016)— · 1 papers (2016–2016)Tsen‐Fang Tsai · National Taiwan University1 papers (2014–2014)— · 1 papers (2016–2016)— · 1 papers (2016–2016)Marianne Notter · Novartis (Switzerland)1 papers (2014–2014)Alice B. Gottlieb · Yale University1 papers (2016–2016)Isabelle Hampele · Novartis (Switzerland)1 papers (2014–2014)Mary Helen Tran · University of California System1 papers (2016–2016)